Clinical Psychopharmacology and Neuroscience focuses on the treatment of psychiatric and neurological disorders. Recent articles discuss the efficacy of various pharmacological interventions, including clozapine for psychosis in XXX syndrome, olanzapine long-acting injections, and the combination of naltrexone and baclofen for alcohol dependence. The journal also explores non-invasive neuromodulation techniques like transcranial direct and alternating current stimulation (tDCS and tACS) for neuropsychiatric conditions. Furthermore, it examines the application of digital psychiatry, particularly virtual and augmented reality, in treating disorders such as anxiety, PTSD, and autism spectrum disorder.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Behavioral NeuroscienceQ2
Pharmacology (medical)Q2
Psychiatry and Mental HealthQ2
Subject Classification
Web of Science Categories
NeurosciencesPharmacology & Pharmacy
Scopus Categories
Pharmacology (medical)Psychiatry and Mental HealthBehavioral Neuroscience
Research Topics (OpenAlex)
Schizophrenia research and treatmentTryptophan and brain disordersTreatment of Major DepressionBipolar Disorder and TreatmentAttention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorElectroconvulsive Therapy StudiesAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesStress Responses and CortisolObsessive-Compulsive Spectrum Disorders